NCT05856123

Brief Summary

The purpose of this research is to test an investigational device called SimPull to see if it is a more efficient method of transferring a patient from one bed to another compared to that of current methods. The purpose of this research is to gather information on the safety and effectiveness of the SimPull device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 12, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

November 16, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

October 22, 2025

Completed
Last Updated

October 22, 2025

Status Verified

August 1, 2025

Enrollment Period

9 months

First QC Date

May 4, 2023

Results QC Date

August 14, 2025

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Time to Complete Lateral Transfer

    The average total time (minutes) it took to complete a lateral transfer.

    Baseline

  • The Number of Staff Involved in a Transfer

    The average number of staff members engaged during transfers

    Baseline

  • Average Weight of Participants

    The average weight (kilograms) of participants who underwent a lateral transfer

    Baseline

Secondary Outcomes (2)

  • Clinician Satisfaction

    Baseline

  • The Number of Survey Responses From Clinicians Who Indicated They Were Very Likely to Experience Injury During Transfers

    Baseline

Study Arms (3)

Group 1: Standard of Care Transfer

NO INTERVENTION

After cardiac catheterization lab or electrophysiology lab procedure, the subject will be moved from one bed to another using the current standard of practice lateral patient transfer methods by nursing staff.

Group 2: SimPull Device Transfer

EXPERIMENTAL

After cardiac catheterization lab or electrophysiology lab procedure, the subject will be moved from one bed to another using the SimPull device.

Device: SimPull Lateral Transfer Device

Group 3: Clinicians

ACTIVE COMPARATOR

Study clinicians complete a survey after conducting intervention or standard of care on participants.

Other: Survey

Interventions

Automated lateral transfer device

Group 2: SimPull Device Transfer
SurveyOTHER

Complete Survey

Group 3: Clinicians

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring lateral transfer for an invasive cardiac procedure to and from gurney to exam table.
  • Patients requiring lateral transfer for an invasive cardiac procedure to and from exam table to gurney.
  • Patient does not have compound fractures or cervical fractures present.
  • Patient does not have skin damage or open wounds to the dorsal cavity.
  • Patient or legally authorized representative (LAR) must be able/present to sign consent.

You may not qualify if:

  • Patients who do not require lateral transfer for an invasive cardiac procedure to and from gurney to exam table.
  • Patients who do not require lateral transfer for an invasive cardiac procedure to and from exam table to gurney.
  • Patient has compound fractures or cervical fractures present.
  • Patient has skin damage or open wounds to the dorsal cavity.
  • Patient or legally authorized representative (LAR) are unable/present to sign consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Arizona

Phoenix, Arizona, 85054, United States

Location

Related Links

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Deanna Covelli
Organization
Mayo Clinic

Study Officials

  • Deanna Covelli, MSN, RN

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 12, 2023

Study Start

November 16, 2023

Primary Completion

August 14, 2024

Study Completion

August 14, 2024

Last Updated

October 22, 2025

Results First Posted

October 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations